1. A case of moderate haemophilia A with inhibitor, carrying the p.R1800H mutation, complicated with juvenile idiopathic arthritis. Issue 1 (3rd December 2018) Authors: Kondo, Yuka; Shida, Yasuaki; Ishikawa, Tomoaki; Yada, Koji; Takeyama, Masahiro; Shima, Midori; Nogami, Keiji Journal: Haemophilia Issue: Volume 25:Issue 1(2019) Page Start: e51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A microchip flow‐chamber assay screens congenital primary hemostasis disorders. Issue 2 (5th December 2020) Authors: Nakajima, Yuto; Yada, Koji; Ogiwara, Kenichi; Furukawa, Shoko; Shimonishi, Naruto; Shima, Midori; Nogami, Keiji Journal: Pediatrics international Issue: Volume 63:Issue 2(2021) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of self‐/parent‐reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN‐52. Issue 2 (24th February 2020) Authors: Furuichi, Yasuko; Nogami, Keiji; Yada, Koji; Nezu, Satoko; Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio; Nakajima, Mitsuru; Kinoshita, Seiji; Shima, Midori Journal: Haemophilia Issue: Volume 26:Issue 2(2020) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2). Issue 5 (11th June 2022) Authors: Nogami, Keiji; Taki, Masashi; Matsushita, Tadashi; Kojima, Tetsuhito; Oka, Toshiaki; Ohga, Shouichi; Kawakami, Kiyoshi; Sakai, Michio; Suzuki, Takashi; Higasa, Satoshi; Horikoshi, Yasuo; Shinozawa, Keiko; Tamura, Shogo; Yada, Koji; Imaizumi, Masue; Ohtsuka, Yoshitoshi; Iwasaki, Fuminori; Kobayash... Journal: Haemophilia Issue: Volume 28:Issue 5(2022) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis. Issue 2 (7th March 2023) Authors: Furukawa, Shoko; Ogiwara, Kenichi; Yada, Koji; Takeyama, Masahiro; Niino, Tomomi; Shima, Midori; Keiji, Nogami Journal: Blood coagulation and fibrinolysis Issue: Volume 34:Issue 2(2023) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Different factor VIII neutralizing effects on anti‐factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor1. (24th July 2013) Authors: Yada, Koji; Nogami, Keiji; Shima, Midori Journal: British journal of haematology Issue: Volume 163:Number 1(2013:Oct.) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V. (20th August 2018) Authors: Yada, Koji; Nogami, Keiji; Shinozawa, Keiko; Kitazawa, Takehisa; Hattori, Kunihiro; Amano, Kagehiro; Fukutake, Katsuyuki; Shima, Midori Journal: British journal of haematology Issue: Volume 183:Number 2(2018) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Factor (F)VIII/VIIa enhances global haemostatic function in the co‐presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor. (2nd April 2018) Authors: Nogami, Keiji; Matsumoto, Tomoko; Yada, Koji; Ogiwara, Kenichi; Furukawa, Shoko; Shida, Yasuaki; Takeyama, Masahiro; Shima, Midori Journal: British journal of haematology Issue: Volume 181:Number 4(2018) Page Start: 528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab. Issue 5 (May 2020) Authors: Yada, Koji; Nogami, Keiji Journal: Arteriosclerosis, thrombosis, and vascular biology Issue: Volume 40:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Risk factors for post-extraction bleeding in patients with haemophilia: a retrospective cohort study. Issue 3 (April 2021) Authors: Yagyuu, Takahiro; Yata, Sachiko; Imada, Mitsuhiko; Funayama, Naoki; Imai, Yuichiro; Yada, Koji; Nogami, Keiji; Kirita, Tadaaki Journal: British journal of oral and maxillofacial surgery Issue: Volume 59:Issue 3(2021) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗